Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 51,313 | 44,367 | 39,631 | 69,886 | 67,205 |
| Gross Profit | 51,313 | 44,367 | 39,631 | 69,886 | 67,205 |
| Operating Expenses | 44,882 | 40,612 | 40,935 | 42,030 | 32,753 |
| Operating Income | 6,431 | 3,755 | -1,304 | 27,856 | 34,452 |
| Other Income | 2,274 | 2,415 | 2,245 | 1,885 | 1,429 |
| Pre-tax Income | 8,705 | 6,170 | 941 | 29,741 | 35,881 |
| Income Tax | -486 | -866 | -3,204 | 3,730 | 8,461 |
| Net Income Continuous | 9,191 | 7,036 | 4,145 | 26,011 | 27,420 |
| Net Income | $9,191 | $7,036 | $4,145 | $26,011 | $27,420 |
| EPS Basic Total Ops | 0.46 | 0.36 | 0.21 | 1.34 | 1.43 |
| EPS Basic Continuous Ops | 0.46 | 0.36 | 0.21 | 1.34 | 1.42 |
| EPS Diluted Total Ops | 0.43 | 0.33 | 0.20 | 1.25 | 1.31 |
| EPS Diluted Continuous Ops | 0.43 | 0.33 | 0.20 | 1.25 | 1.32 |
| EBITDA(a) | $6,475 | $3,364 | $-1,738 | $27,559 | $34,516 |